This study clarifies the regulation of NR4A1 in NIH3T3 and demonstrates its role in PDGF-BB-meditated cell transformation both in NIH3T3 and in glioblastoma-derived cell lines; our findings suggest that NR4A1 may be a target in cancer treatment. This evidence concerns the gene NR4A1 and cancer.